Tumour‐derived extracellular vesicle membrane hybrid lipid nanovesicles enhance siRNA delivery by tumour‐homing and intracellular freeway transportation
Open Access
- 1 March 2022
- journal article
- research article
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 11 (3) , e12198
Abstract
Extracellular vesicles (EVs) have been proved a promising small interfering RNA (siRNA) delivery vehicle to mediate gene‐silencing. Tumour‐derived extracellular vesicles (TDEVs) as genetic exchange vectors in the tumour microenvironment, enable intercellular communication for a wide range of endogenous cargo molecules, such as RNAs and proteins. However, the oncogenic cargo of TDEVs limits their application in siRNA delivery for cancer therapy. Herein, we isolated TDEVs from hepatocellular carcinoma (HCC) cells and derived TDEV membranes by abandoning their content. Innovative TDEV membrane hybrid lipid nanovesicles (LEVs) were then fabricated by fusion of TDEV membranes and phospholipids to realize precise delivery to tumours and highly efficient transfection of siRNA. The TDEV membranes endow LEVs with ‘homing’ targeting ability, facilitating specific internalisation into parent HCC cells primarily through heparan sulfate proteoglycan‐mediated pathways. Unlike conventional lipid‐based nanovesicles, LEVs can bypass the endosomal degradation pathway, boost the delivery of siRNA through the Golgi and endoplasmic reticulum (ER) intracellular ‘freeway’ transportation, achieving a 1.7‐fold improvement in siRNA transfection efficiency compared with liposomes. Additionally, siRNA loaded LEVs were demonstrated to enhance the antitumour efficacy in HCC bearing mice through effective gene silencing in the tumour sites. Our results highlight the potential application of the TDEV membrane‐derived nanovesicles as an advanced siRNA delivery strategy for cancer therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81973250, 82025032)
- Natural Science Foundation of Shanghai Municipality (21ZR1475800)
- State Key Laboratory of Drug Research, Chinese Academy of Sciences (SIMM2103ZZ‐01)
This publication has 35 references indexed in Scilit:
- Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell InteractionsJournal of Biological Chemistry, 2016
- Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowthNature, 2015
- Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3Medical Oncology, 2015
- Non-viral vectors for gene-based therapyNature Reviews Genetics, 2014
- Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activityProceedings of the National Academy of Sciences of the United States of America, 2013
- Exosomes in cancer development, metastasis, and drug resistance: a comprehensive reviewCancer and Metastasis Reviews, 2013
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomesNature Biotechnology, 2011
- Exosomes and Cancer: A Newly Described Pathway of Immune SuppressionClinical Cancer Research, 2011
- Inhibition of CDK1 as a potential therapy for tumors over-expressing MYCNature Medicine, 2007
- Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosisBlood Cells, Molecules, and Diseases, 2005